Seqens Seqens

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Digital content for NKGen Biotech

    Client Virtual Booth

    NKGEN BIOTECH

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass
    Contact SupplierContact Supplier
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Send me more info on How To Grow My Bussiness Digitally?
    NKGen Biotech
    United_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    3001 Daimler St, Santa Ana, California 92705
    Telephone
    Telephone
    949-396-6830
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://nkgenbiotech.com/about-us/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nkgen-biotech-inc/
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Full View ScreenFull Screen View
    NKGen Biotech to Present at ASCO 2024 Annual Meeting
    NKGen Biotech to Present at ASCO 2024 Annual Meeting

    https://www.globenewswire.com/news-release/2024/04/24/2869147/0/en/NKGen-Biotech-Announces-Upcoming-Publication-at-the-2024-American-Society-of-Clinical-Oncology-ASCO-Annual-Meeting.html

    GLOBENEWSWIRE
    24 Apr 2024
    Share Share
    NKGen Biotech Presenting SNK01 NK Cell Therapy At Alzheimer's Summit
    NKGen Biotech Presenting SNK01 NK Cell Therapy At Alzheimer's Summit

    https://www.globenewswire.com/news-release/2024/04/18/2865818/0/en/NKGen-Biotech-Announces-Upcoming-Presentation-on-SNK01-NK-Cell-Therapy-in-Neurodegenerative-Disease-at-the-12th-Annual-Alzheimer-s-Parkinson-s-Drug-Development-Summit.html

    GLOBENEWSWIRE
    18 Apr 2024
    Share Share
    NKGen Biotech Raises $5M To Advance Clinical Programs
    NKGen Biotech Raises $5M To Advance Clinical Programs

    https://www.globenewswire.com/news-release/2024/04/11/2861470/0/en/NKGen-Biotech-Secures-Additional-Financing-of-5-Million-to-Continue-Advancing-Its-Clinical-Programs.html

    GLOBENEWSWIRE
    11 Apr 2024
    Share Share
    NKGen Biotech Presents Additional Ph 1 Trial Data in ADisease at the Tau2024
    NKGen Biotech Presents Additional Ph 1 Trial Data in ADisease at the Tau2024

    https://www.globenewswire.com/news-release/2024/03/25/2851989/0/en/NKGen-Biotech-Presents-Additional-Phase-1-Clinical-Trial-Data-in-Alzheimer-s-Disease-at-the-Tau2024-Global-Conference.html

    GLOBENEWSWIRE
    25 Mar 2024
    Share Share
    NKGen Biotech Announces Upcoming Presentation on SNK01
    NKGen Biotech Announces Upcoming Presentation on SNK01

    https://www.globenewswire.com//news-release/2024/03/04/2839534/0/en/NKGen-Biotech-Announces-Upcoming-Presentation-on-SNK01-in-Alzheimer-s-Disease-at-the-Tau2024-Global-Conference.html

    GLOBENEWSWIRE
    04 Mar 2024
    Share Share
    NKGen Announces Dosing of First Patient in its Phase 1/2a Trial with SNK01
    NKGen Announces Dosing of First Patient in its Phase 1/2a Trial with SNK01

    https://www.globenewswire.com//news-release/2023/12/28/2801852/0/en/NKGen-Biotech-Inc-Announces-Dosing-of-First-Patient-in-its-Phase-1-2a-Trial-with-Autologous-NK-Cell-Product-SNK01-for-the-Treatment-of-Moderate-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    28 Dec 2023
    Share Share
    NKGen Biotech Announces Clearance of Trial Application by HC for SNK01
    NKGen Biotech Announces Clearance of Trial Application by HC for SNK01

    https://www.globenewswire.com//news-release/2023/12/27/2801339/0/en/NKGen-Biotech-Announces-Clearance-of-Clinical-Trial-Application-by-Health-Canada-for-SNK01-NK-Cell-Therapy-to-Treat-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    27 Dec 2023
    Share Share
    NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results
    NKGen Biotech, Inc. Reports Third Quarter 2023 Financial Results

    https://www.globenewswire.com//news-release/2023/11/14/2780588/0/en/NKGen-Biotech-Inc-Reports-Third-Quarter-2023-Financial-Results-and-Business-Highlights.html

    GLOBENEWSWIRE
    14 Nov 2023
    Share Share
    NKGen Presented Phase I Clinical Trial Data at the 16th Annual CTAD Conference
    NKGen Presented Phase I Clinical Trial Data at the 16th Annual CTAD Conference

    https://www.globenewswire.com//news-release/2023/10/26/2767459/0/en/NKGen-Biotech-Presented-Phase-I-Clinical-Trial-Data-at-the-16th-Annual-Clinical-Trials-on-Alzheimer-s-Disease-CTAD-Conference.html

    GLOBENEWSWIRE
    26 Oct 2023
    Share Share
    NKGen Biotech Announces FDA Clearance of Investigational NDA for SNK01
    NKGen Biotech Announces FDA Clearance of Investigational NDA for SNK01

    https://www.globenewswire.com//news-release/2023/10/24/2765577/0/en/NKGen-Biotech-Announces-FDA-Clearance-of-Investigational-New-Drug-Application-for-SNK01-NK-Cell-Therapy-to-Treat-Alzheimer-s-Disease.html

    GLOBENEWSWIRE
    24 Oct 2023
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    veranova-m-2024-04-22

    Access Virtual Booth

    Contact Supplier

    Send me more info on How To Grow My Business Digitally?
    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search